Skip to content

Therapeutic Evaluation of Unani Formulation in Salas al-Bawl (Stress Urinary Incontinence): A Randomized Controlled Study.

Therapeutic Evaluation of Unani Formulation in Salas al-Bawl (Stress Urinary Incontinence): A Randomized Controlled Study. - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/03/082716
Enrollment
40
Registered
2025-03-19
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N319- Neuromuscular dysfunction of bladder, unspecified Health Condition 2: N319- Neuromuscular dysfunction of bladder, unspecified Health Condition 3: N319- Neuromuscular dysfunction of bladder, unspecified

Interventions

Intervention1: Polyherbal Unani formulation: Kunjud siya(sesamum indicum) Nankhawa (Trachyspermum Ammi) Qand siya (Saccharum Officinarum) Above medicines are taken in equal quantity will be powdere

Sponsors

shahila nigar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Married women above the age group of 21-60 years. Clinically diagnosed patients of stress urinary incontinence willing to participate in the study.

Exclusion criteria

Exclusion criteria: Pregnant and lactating women. Patients with 3rd and 4th degree genital prolapse. H/o systemic illnesses, endocrinal diseases and malignancies. H/o any pharmacological intervention within 3 months and have had surgical intervention for SUI.

Design outcomes

Primary

MeasureTime frame
Reduction in the number of incontinent episodes assessed by bladder diary. Reduction in ICIQ-SF score.Timepoint: Baseline (0day), 15th day, 30th day, 45th day and 60th day

Secondary

MeasureTime frame
Pelvic floor muscle strength assessed by Modified Oxford Grading ScaleTimepoint: Baseline (0day), 15th day, 30th day, 45th day and 60th day

Countries

India

Contacts

Public ContactDr Juveriya Naaz Bhusnur
drjuveriya10@gmail.com7406810517

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026